The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Merck & Co. agreed to buy UK biotech Verona Pharma Plc for about $10 billion as part of a wider push to offset the looming ...

The visit spotlighted the emirate’s achievements in AI, digital health, genomics, and clinical research, and showcased Abu ...

The £810,000 fundraise was led by with a £500,000 equity investment from the Development Bank of Wales. Amotio will use the ...

Use of lasers for dermatologic conditions in pediatric patients brings challenges, from psychosocial and informed consent issues to pain management.

Two of Cytiva’s top executives offer updates on the company's $1.6 billion in expansion projects worldwide, all to meet growing market demand for its services from developers and manufacturers of ...

Armed with the latest biological knowledge and cutting-edge computational techniques—and, of course, investor dollars—these ...

US clinical-stage biotech ProKidney reported statistically-significant and clinically-meaningful positive top-line results ...

Leerink Partners called the announcement a ‘positive’ given the delayed timeframe and the uncertainty that the administration ...

A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...

Prior to joining Crescent, Dr Pinkas was CSO at Pyxis Oncology (Nasdaq: PYXS), where he established the preclinical research ...

The global dysmenorrhea treatment market, valued at approximately USD 5,937.8 million in 2022, is projected to reach USD 6,324.5 million in 2023 and USD 13,106.5 million by 2032, exhibiting a CAGR of ...